September 25, 2007 - The risk of developing venous thromboembolism while flying on an airplane, a condition known as “economy class syndrome,” is only about one in 5,000 for long flights, although the odds of in-flight clot are higher for some groups, according to a new study out of The Netherlands.
September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel ...
September 25, 2007 - The Sorin Group, a European cardiovascular company, announced today that it has received FDA ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...
September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery ...
September 21, 2007 - Catheter angiography may be unnecessary in cases where the CT angiogram (CTA) is indeterminate for ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse ...
September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.
September 20, 2007 - Cook Medical and Cardica Inc. announced that they have expanded their original agreement regarding ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and ...
September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the ...
September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 19, 2007 - For patients with equivocal or discordant findings on myocardial perfusion imaging, CT angiography ...
September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) ...
September 19, 2007 - Risk stratification using single-photon emission computed tomography (SPECT) led to shorter stays ...